Literature DB >> 6996003

Mechanism of emetine cardiotoxicity.

W C Yang, M Dubick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6996003     DOI： 10.1016/0163-7258(80)90007-8

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  5 in total

Review 1.  Different Aspects of Emetine's Capabilities as a Highly Potent SARS-CoV-2 Inhibitor against COVID-19.

Authors:  Mehdi Valipour
Journal:  ACS Pharmacol Transl Sci       Date:  2022-05-23

2.  Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry.

Authors:  Shu Yang; Miao Xu; Emily M Lee; Xiangguo Qiu; Alexey V Terskikh; Hengli Tang; Hongjun Song; Wei Zheng; Kirill Gorshkov; Sergey A Shiryaev; Shihua He; Wei Sun; Yu-Shan Cheng; Xin Hu; Anil Mathew Tharappel; Billy Lu; Antonella Pinto; Chen Farhy; Chun-Teng Huang; Zirui Zhang; Wenjun Zhu; Yuying Wu; Yi Zhou; Guang Song; Heng Zhu; Khalida Shamim; Carles Martínez-Romero; Adolfo García-Sastre; Richard A Preston; Dushyantha T Jayaweera; Ruili Huang; Wenwei Huang; Menghang Xia; Anton Simeonov; Guoli Ming
Journal:  Cell Discov       Date:  2018-06-05       Impact factor: 10.849

Review 3.  Repurposing of medications for pulmonary arterial hypertension.

Authors:  Mark Toshner; Edda Spiekerkoetter; Harm Bogaard; Georg Hansmann; Sylvia Nikkho; Kurt W Prins
Journal:  Pulm Circ       Date:  2020-11-18       Impact factor: 3.017

4.  Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate.

Authors:  Holly Matthews; Maryam Usman-Idris; Farid Khan; Martin Read; Niroshini Nirmalan
Journal:  Malar J       Date:  2013-10-09       Impact factor: 2.979

5.  Lead Optimization of Dehydroemetine for Repositioned Use in Malaria.

Authors:  Priyanka Panwar; Kepa K Burusco; Muna Abubaker; Holly Matthews; Andrey Gutnov; Elena Fernández-Álvaro; Richard A Bryce; James Wilkinson; Niroshini Nirmalan
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.